Evidence
Curr Opin Cell Biol. 2024 Feb 23;87:102340. doi: 10.1016/j.ceb.2024.102340. Online ahead of print.
ABSTRACT
Glial fibrillary acidic protein (GFAP) is an intermediate filament (IF) protein expressed in specific types of glial cells in the nervous system. The expression of GFAP is highly regulated during brain development and in neurological diseases. The presence of distinct GFAP-isoforms in various cell types, developmental stages, and diseases indicates that GFAP (post-)transcriptional regulation has a role in glial cell physiology and pathology. GFAP-isoforms differ in sub-cellular localisation, IF-network assembly properties, and IF-dynamics which results in distinct molecular interactions and mechanical properties of the IF-network. Therefore, GFAP (post-)transcriptional regulation is likely a mechanism by which radial glia, astrocytes, and glioma cells can modulate cellular function.
PMID:38401182 | DOI:10.1016/j.ceb.2024.102340
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
GFAP-isoforms in the nervous system: Understanding the need for diversity
🌐 90 Days
VR Related Evidence Matrix
- Morphological and electrophysiological characterization of a novel displaced astrocyte in the mouse retina
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest
- Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank
- Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy
- Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease
- Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease
- NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease
- Repair effect of different doses of human umbilical cord mesenchymal stem cells on white matter injury in neonatal rats
- Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19
- Glial Cell Development and Function in the Zebrafish Central Nervous System
- Craniofacial anomalies in schizophrenia-relevant GFAP.HMOX1(0-12m) mice
- Reversibility of Endoplasmic Reticulum Stress Markers During Long-Term Glucose Starvation in Astrocytes
- Neuronal Panx1 drives peripheral sensitization in experimental plantar inflammatory pain
- Racial discrimination during middle age predicts higher serum phosphorylated tau and neurofilament light chain levels a decade later: A study of aging black Americans
- Lineage Analysis and Birthdating of Drosophila Central Complex Lineages
- Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population
- Adolescent alcohol binge drinking and withdrawal: behavioural, brain GFAP-positive astrocytes and acute methamphetamine effects in adult female rats
- Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI
- Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI
- Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies
- Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis
- Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 Isoforms
- Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease
- Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy
- Shared inflammatory glial cell signature after stab wound injury, revealed by spatial, temporal, and cell-type-specific profiling of the murine cerebral cortex
- Comparative Study of Virus and Lymphocyte Distribution with clinical Data suggests early high dose Immunosuppression as potential Key Factor for the Therapy of Patients with BoDV-1 Infection
- Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study
- Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol
- Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol
- Dorsal hippocampal astrocytes mediate the development of heroin withdrawal-enhanced fear learning
- Present and future of Blood-Based biomarkers of Alzheimer's Disease: Beyond the classics
- Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD
- Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial
- Extracellular ATP is a homeostatic messenger that mediates cell‒cell communication in physiological processes and psychiatric diseases
- Extracellular ATP is a homeostatic messenger that mediates cell‒cell communication in physiological processes and psychiatric diseases
- Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
- Edaravone Maintains AQP4 Polarity Via OS/MMP9/β-DG Pathway in an Experimental Intracerebral Hemorrhage Mouse Model
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- Overexpression of pathogenic tau in astrocytes causes a reduction in AQP4 and GLT1, an immunosuppressed phenotype and unique transcriptional responses to repetitive mild TBI without appreciable changes in tauopathy
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Generation and characterization of cerebellar granule neurons specific knockout mice of Golli-MBP
- Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
- NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression
- NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model
- Single-cell RNA-seq data analysis reveals functionally relevant biomarkers of early brain development and their regulatory footprints in human embryonic stem cells (hESCs)
- Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics
- Generation of human cerebral organoids with a structured outer subventricular zone
- Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season
- Implication of system xc- in neuroinflammation during the onset and maintenance of neuropathic pain
- Expression changes of RNA m6A regulators in mouse cerebellum affected by hypobaric hypoxia stimulation
- Expression changes of RNA m6A regulators in mouse cerebellum affected by hypobaric hypoxia stimulation
- Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
- Nacc1 mutation in mice models rare neurodevelopmental disorder with underlying synaptic dysfunction
- Acellular spinal cord scaffold containing quercetin-encapsulated nanoparticles plays an anti-inflammatory role in functional recovery from spinal cord injury in rats
- Acellular spinal cord scaffold containing quercetin-encapsulated nanoparticles plays an anti-inflammatory role in functional recovery from spinal cord injury in rats
- ESCRT-I protein UBAP1 controls ventricular expansion and cortical neurogenesis via modulating adherens junctions of radial glial cells
- CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain
- Dynamin1 long- and short-tail isoforms exploit distinct recruitment and spatial patterns to form endocytic nanoclusters
- Depletion of Mettl3 in cholinergic neurons causes adult-onset neuromuscular degeneration
- Expression of truncated products at the 5'-terminal region of RIPK2 and evolutive aspects that support their biological importance
- Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease
Evidence Blueprint
GFAP-isoforms in the nervous system: Understanding the need for diversity
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
GFAP-isoforms in the nervous system: Understanding the need for diversity
🌐 365 Days
VR Related Evidence Matrix
- Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP)
- New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis
- Evaluation of 18F labeled glial fibrillary acidic protein binding nanobody and its brain shuttle peptide fusion proteins using a neuroinflammation rat model
- Morphological and electrophysiological characterization of a novel displaced astrocyte in the mouse retina
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19
- FXTAS neuropathology includes widespread reactive astrogliosis and white matter specific astrocyte degeneration
- Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest
- The association between personality and plasma biomarkers of astrogliosis and neuronal injury
- Preliminary Evaluation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries with Glial Fibrillary Acidic Protein
- Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank
- Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy
- The Effect of Prenatal and Neonatal Fluoride Exposure to Morphine-Induced Neuroinflammation
- Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
- Synaptopodin-2 Isoforms Have Specific Binding Partners and Display Distinct, Muscle Cell Type-Specific Expression Patterns
- Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease
- Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease
- Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study
- Glial cell response and microthrombosis in aneurysmal subarachnoid hemorrhage patients: An autopsy study
- NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease
- Repair effect of different doses of human umbilical cord mesenchymal stem cells on white matter injury in neonatal rats
- Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study
- Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP
- Head Kinematics, Blood Biomarkers and Histology in Large Animal Models of Traumatic Brain Injury and Hemorrhagic Shock
- Hypotension during transsphenoidal pituitary surgery associated with increase in plasma levels of brain injury markers
- Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19
- Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression
- Brazil Nut-Enriched Diet Modulates Enteric Glial Cells and Gut Microbiota in an Experimental Model of Chronic Kidney Disease
- A Drosophila glial cell atlas reveals a mismatch between transcriptional and morphological diversity
- High burdens of phosphorylated tau protein and distinct precuneus atrophy in sporadic early-onset Alzheimer's disease
- Glial Cell Development and Function in the Zebrafish Central Nervous System
- Craniofacial anomalies in schizophrenia-relevant GFAP.HMOX1(0-12m) mice
- Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic
- Vascular risk factors and astrocytic marker for the glymphatic system activity
- Dysregulated glial genes in Alzheimer's disease are essential for homeostatic plasticity: Evidence from integrative epigenetic and single cell analyses
- Rosiglitazone attenuates amyloid beta and glial fibrillary acidic protein in the hippocampus and neuroinflammation associated learning and memory impairments in rats
- Reversibility of Endoplasmic Reticulum Stress Markers During Long-Term Glucose Starvation in Astrocytes
- Neuronal Panx1 drives peripheral sensitization in experimental plantar inflammatory pain
- Yigong Powder regulates CXCL12/CXCR4 signaling to reduce glutamate release and prevent cognitive decline in mouse model of aging
- Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort
- Plasma biomarker profile and clinical correlations in adult patients with Tuberous Sclerosis Complex
- Regulation and function of alternative polyadenylation in development and differentiation
- Racial discrimination during middle age predicts higher serum phosphorylated tau and neurofilament light chain levels a decade later: A study of aging black Americans
- Lineage Analysis and Birthdating of Drosophila Central Complex Lineages
- Innate and adaptive immune gene expression in the brain is associated with neuropathological changes after infection with bovine alpha-herpesvirus-5 in mice
- Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population
- Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
- Adolescent alcohol binge drinking and withdrawal: behavioural, brain GFAP-positive astrocytes and acute methamphetamine effects in adult female rats
- Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI
- Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI
- Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid
- Calcified Pilocytic Astrocytomas and Calcifying Pseudoneoplasms of the Neuraxis: A Diagnostic Challenge
- Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies
- Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis
- Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 Isoforms
- Evaluating the effect of post-traumatic hypoxia on the development of axonal injury following traumatic brain injury in sheep
- HLA-II-Dependent Neuroimmune Changes in Group A Streptococcal Necrotizing Fasciitis
- Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease
- Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy
- Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change
- Association of Neurofilament Light Chain, [18F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
- Shared inflammatory glial cell signature after stab wound injury, revealed by spatial, temporal, and cell-type-specific profiling of the murine cerebral cortex
- Microglia and Astroglia-The Potential Role in Neuroinflammation Induced by Pre- and Neonatal Exposure to Lead (Pb)
- Comparative Study of Virus and Lymphocyte Distribution with clinical Data suggests early high dose Immunosuppression as potential Key Factor for the Therapy of Patients with BoDV-1 Infection